CD9 and neuroblastoma: Kaplan-Meier analysis showed that high-level CD9 expression in tumors, irregardless of International Neuroblastoma Staging System (INSS) stage or patient age, correlated both with favorable event-free and overall patient survival (Figure 2A-2F and Supplementary Figure S1A-S1D).